

| Prescription required. Online consultation available. |
Bimatoprost 0.03% is a prescription-only eyelash growth treatment with a well-established clinical evidence base. Applied once daily to the base of the upper lashes, it works by extending the natural eyelash growth cycle (the anagen phase), resulting in visibly longer, thicker, and darker lashes over a course of weeks.
Bimatoprost is the same active ingredient found in Latisse — the first and only FDA-approved treatment for inadequate or insufficient eyelashes (hypotrichosis) — and has been the subject of multiple peer-reviewed clinical studies confirming its efficacy for eyelash enhancement.
Bimatoprost is a synthetic prostamide analogue that mimics the effects of naturally occurring prostamides in the body. When applied to the lash line, it prolongs the anagen (active growth) phase of the eyelash hair cycle and increases the number of hairs in this phase simultaneously. The result is a gradual but significant improvement in lash length, thickness, and pigmentation over the treatment period.
Consistent daily use is essential to maintain results. If treatment is stopped, lashes will gradually return to their previous appearance over several weeks.
Bimatoprost 0.03% is a prescription medication, not a cosmetic product. A valid prescription issued by a registered prescriber is required before dispensing. Do not use this product without a prescription.
Possible side effects include:
If you experience any of these side effects, discontinue use and contact your prescriber. This product is not suitable for use during pregnancy or breastfeeding without medical advice.
Yes. Bimatoprost 0.03% is a prescription-only medicine (POM) in the UK. You will need to complete an online consultation with one of our independent prescribers before this product can be dispensed. The consultation is straightforward and can be completed entirely online.
Most patients begin to notice a difference from around 4 weeks of consistent daily use. Full results — including maximum length, thickness, and darkness — are typically achieved at 16 weeks. Results are maintained with continued use.
If treatment is discontinued, eyelashes will gradually return to their previous appearance over a period of several weeks as the hair cycle normalises. To maintain results, ongoing daily application is required.
Bimatoprost is the active ingredient in Latisse, which is the FDA-approved branded version of the same treatment. The active ingredient and mechanism of action are identical. Bimatoprost 0.03% eye drops contain the same concentration used in Latisse.
Bimatoprost is licensed for eyelash use only. While some clinicians use it off-label for eyebrow enhancement, this is outside the licensed indication. We offer dedicated eyebrow growth treatments — please speak to your prescriber for guidance.
Yes, but contact lenses must be removed before application and reinserted no sooner than 15 minutes afterwards. The solution contains preservatives that can be absorbed by soft contact lenses.
Iris darkening (increased brown pigmentation) is a known side effect of bimatoprost and other prostaglandin analogues. This change may be permanent and is more likely with prolonged use. It is more commonly associated with direct eye drop use (e.g. for glaucoma) than with lash-line application, but patients should be aware of this risk.
This is a prescription-only medicine. Always read the patient information leaflet supplied with your medication. If you have any questions about your treatment, contact your prescriber or a registered pharmacist. Do not share this medication with others, even if their symptoms appear similar to yours.
People with a history of ocular conditions, uveitis, macular oedema, or sensitivity to prostaglandin analogues should inform their prescriber before starting treatment.